Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
ASX:CSL
CSL
|
283.05 | 21,27% | 41,99% | 136.784,68 | 1,27% | 7,18% |
|
TSE:4568
Daiichi Sankyo Company
|
5486.00 | 0% | 0% | 10.516.360,76 | 1,11% | 0% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4159.00 | 0% | 0% | 6.525.195,89 | 4,66% | 0% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
80.40 | 142,2% | 221,62% | 15.385,96 | 0% | 32,46% |
|
TSE:4507
Shionogi &
|
7254.00 | 0% | 0% | 2.162.756,31 | 2,05% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
39.21 | -.156,68% | -.149,23% | 5.756,54 | 0% | 0% |
|
NasdaqGM:NTLA
Intellia Therapeutics
|
26.22 | 0% | 0% | 2.359,79 | 0% | 0% |
|
ENXTAM:PHARM
Pharming Group N.V.
|
0.85 | -.641,75% | 1.467,17% | 591,95 | 0% | 0% |
|
NasdaqGM:KALV
KalVista Pharmaceuticals
|
12.01 | 0% | 0% | 478,84 | 0% | 0% |
